600 related articles for article (PubMed ID: 25613095)
1. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
3. Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsyitle.
Van Campenhout A; Bar-On L; Desloovere K; Molenaers G
Acta Orthop Belg; 2015 Jun; 81(2):167-71. PubMed ID: 26280952
[TBL] [Abstract][Full Text] [Related]
4. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
5. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
Barrett RS
Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
[No Abstract] [Full Text] [Related]
6. [Treatment with botulinum toxin in neurologic pediatrics].
Justus N; Lee SH; Berweck S; Heinen F
Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
[No Abstract] [Full Text] [Related]
7. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
Ade-Hall RA; Moore AP
Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
9. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S
Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
[TBL] [Abstract][Full Text] [Related]
10. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
Lorin K; Forsberg A
Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
[TBL] [Abstract][Full Text] [Related]
11. Sonography-guided injection of botulinum toxin A in children with cerebral palsy.
Berweck S; Feldkamp A; Francke A; Nehles J; Schwerin A; Heinen F
Neuropediatrics; 2002 Aug; 33(4):221-3. PubMed ID: 12368994
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
13. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
[TBL] [Abstract][Full Text] [Related]
14. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
15. Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.
Placzek R; Siebold D; Funk JF
Toxins (Basel); 2010 Sep; 2(9):2258-71. PubMed ID: 22069684
[TBL] [Abstract][Full Text] [Related]
16. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
17. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
[TBL] [Abstract][Full Text] [Related]
19. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
Koman LA; Paterson Smith B; Balkrishnan R
Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
Dai A
J Rehabil Med; 2007 Mar; 39(2):189; author reply 189. PubMed ID: 17351705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
